CD133-regulated nucleophosmin expression in human colon cancer cells by Kun Kim et al.
MEETING ABSTRACT Open Access
CD133-regulated nucleophosmin expression in
human colon cancer cells
Kun Kim1,2, Kyung-Hee Kim1,2*, Seung Cheol Kim3, Jun Pyu Hong1, Won Ki Kim1, Byong Chul Yoo1†, Ja-Lok Ku2
From EPMA-World Congress 2013
Brussels, Belgium. 20-21 September 2013
Cancer stem cells (CSCs) are known to be resistant to
conventional chemotherapy and radiotherapy. Specific
CSC targeting and eradication is therefore a therapeuti-
cally important challenge. CD133 is a colorectal CSC
marker with unknown function(s). Assessing proteomic
changes induced by CD133 expression may provide
clues not only to new CD133 functions but also to the
chemotherapy and radiation susceptibility of colon can-
cer cells. To identify the proteins affected by CD133
expression, CD133-positive (CD133+) and CD133-nega-
tive (CD133–) human colon cancer cells were obtained
by cell sorting. Whole proteomes were profiled from
SW620/CD133+ and SW620/CD133– cells and analyzed
by two-dimensional-based proteome analysis. Nucleo-
phosmin (NPM1) was identified as a protein regulated
by CD133. CD133 expression was not affected by
NPM1, and an interaction between the two proteins was
not observed. CD133 and NPM1 expression was posi-
tively correlated in 11 human colon cancer cell lines.
However, the CD133+ subpopulation percentage or its
value normalized against CD133 expression was only
linked to intrinsic susceptibility of human colon cancer
cells to 5-fluorouracil. The present study suggests that
CD133-regulated NPM1 expression may provide a clue
to novel CD133 function(s) linked to human colon can-
cer cell susceptibility to chemotherapy and radiation
therapy.
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